HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) PHENOTYPE AND INTERLEUKIN-2 INTERLEUKIN-10 RATIO ARE ASSOCIATED MARKERS OF PROTECTION AND PROGRESSION INHIV-INFECTION/
M. Clerici et al., HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) PHENOTYPE AND INTERLEUKIN-2 INTERLEUKIN-10 RATIO ARE ASSOCIATED MARKERS OF PROTECTION AND PROGRESSION INHIV-INFECTION/, Blood, 88(2), 1996, pp. 574-579
Human immunodeficiency virus (HIV) isolability, rate of viral replicat
ion, HIV phenotype, type 1 and type 2 cytokine production, and CD4 cou
nts were cross-sectionally analyzed in 63 HIV-seropositive (HIV+) indi
viduals to establish possible correlations between virologic and immun
ologic markers of protection and progression. We observed that these m
arkers are tightly correlated. Thus, lack or low prevalence of HIV iso
lability and the presence of nonsyncitium inducing strains are associa
ted with the strongest type 1 cytokine production, the weakest type 2
cytokine production, and highest CD4 counts. Conversely, the isolation
of highly replicating, syncitium-inducing HIV strains is associated w
ith the weakest type 1 cytokine production, the strongest type 2 cytok
ine production, and lowest CD4 counts, Additionally, it was determined
that the interleukin (IL)-10/IL-2 ratio best discriminates among diff
erent virologic scenarios. These data suggest that the virologic and i
mmunologic correlates of disease protection and progression might be a
ssociated variables that define two different subsets of HIV+ individu
als and lend support to a vitro-immunologic hypothesis of HIV infectio
n. (C) 1996 by The American Society of Hematology.